Correspondence 0001493152-23-026409 from INVO Fertility, Inc. (IVF)
INVO Fertility, Inc.
Date: Aug. 2, 2023 · CIK: 0001417926 · Accession: 0001493152-23-026409
AI Filing Summary & Sentiment
File numbers found in text: 333-273174
Letter
INVO BIOSCIENCE, INC.
BROADCAST COURT
Sarasota, florida 32240
August 2, 2023
U.S. Securities and Exchange Commission
Division of Corporation Finance
F Street, N.E.
Washington, D.C. 20549
Re: INVO Bioscience, Inc.
Registration Statement on Form S-1
File No. 333-273174
Ladies and Gentlemen:
INVO Bioscience, Inc. (the “Company”) hereby requests, pursuant to Rule 461 under the Securities Act of 1933, as amended, that the above-referenced registration statement be accelerated to 5:30 p.m., Eastern Time, on Thursday August 3, 2023, or as soon thereafter as practicable.
Very
truly yours,
INVO
BIOSCIENCE, INC.
Show Raw Text
CORRESP
1
filename1.htm
INVO
BIOSCIENCE, INC.
5582
BROADCAST COURT
Sarasota,
florida 32240
August
2, 2023
U.S.
Securities and Exchange Commission
Division
of Corporation Finance
100
F Street, N.E.
Washington,
D.C. 20549
Re:
INVO
Bioscience, Inc.
Registration
Statement on Form S-1
File
No. 333-273174
Ladies
and Gentlemen:
INVO
Bioscience, Inc. (the “Company”) hereby requests, pursuant to Rule 461 under the Securities Act of 1933, as amended, that
the above-referenced registration statement be accelerated to 5:30 p.m., Eastern Time, on Thursday August 3, 2023,
or as soon thereafter as practicable.
Very
truly yours,
INVO
BIOSCIENCE, INC.
By:
/s/
Steven Shum
Steven
Shum
Chief
Executive Officer